ATE299371T1 - Antikonvulsiva zur behandlung von autismus - Google Patents
Antikonvulsiva zur behandlung von autismusInfo
- Publication number
- ATE299371T1 ATE299371T1 AT00904390T AT00904390T ATE299371T1 AT E299371 T1 ATE299371 T1 AT E299371T1 AT 00904390 T AT00904390 T AT 00904390T AT 00904390 T AT00904390 T AT 00904390T AT E299371 T1 ATE299371 T1 AT E299371T1
- Authority
- AT
- Austria
- Prior art keywords
- anticonvulsives
- autism
- treatment
- Prior art date
Links
- 206010003805 Autism Diseases 0.000 title 1
- 208000020706 Autistic disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11910499P | 1999-02-08 | 1999-02-08 | |
| PCT/US2000/001127 WO2000045812A1 (en) | 1999-02-08 | 2000-01-18 | Anticonvulsant derivatives useful in treating autism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE299371T1 true ATE299371T1 (de) | 2005-07-15 |
Family
ID=22382571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00904390T ATE299371T1 (de) | 1999-02-08 | 2000-01-18 | Antikonvulsiva zur behandlung von autismus |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6552000B2 (de) |
| EP (1) | EP1152756B1 (de) |
| JP (1) | JP2002536328A (de) |
| AR (1) | AR029334A1 (de) |
| AT (1) | ATE299371T1 (de) |
| AU (1) | AU763601B2 (de) |
| CA (1) | CA2361584C (de) |
| DE (1) | DE60021252T2 (de) |
| DK (1) | DK1152756T3 (de) |
| ES (1) | ES2244411T3 (de) |
| MX (1) | MXPA01008038A (de) |
| PT (1) | PT1152756E (de) |
| TR (1) | TR200103125T2 (de) |
| WO (1) | WO2000045812A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060020037A1 (en) * | 2004-07-22 | 2006-01-26 | Allergan, Inc. | Tazarotenic acid and esters thereof for treating autism |
| US9327069B2 (en) * | 2004-12-21 | 2016-05-03 | Boston Scientific Neuromodulation Corporation | Methods and systems for treating a medical condition by promoting neural remodeling within the brain |
| US9095713B2 (en) * | 2004-12-21 | 2015-08-04 | Allison M. Foster | Methods and systems for treating autism by decreasing neural activity within the brain |
| US20070038264A1 (en) * | 2004-12-21 | 2007-02-15 | Jaax Kristen N | Methods and systems for treating autism |
| US20070034214A1 (en) * | 2005-08-12 | 2007-02-15 | Dochniak Michael J | Method to affect the development of autism spectrum disorders |
| US20090076128A1 (en) * | 2007-09-15 | 2009-03-19 | Protia Llc | Deuterium-enriched topiramate |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| EP3149211A1 (de) * | 2014-05-30 | 2017-04-05 | The Children's Hospital of Philadelphia | Genetische veränderungen im zusammenhang mit autismus und autistischem phänotyp und verfahren zur diagnose und behandlung von autismus |
| US11219617B2 (en) | 2014-05-30 | 2022-01-11 | The Children's Hospital Of Philadelphia | Methods of diagnosing and treating autism |
| US10206901B2 (en) | 2016-09-21 | 2019-02-19 | JC Pharma, Inc. | Method and composition for acute treatment of seizures |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| US5753693A (en) | 1996-06-28 | 1998-05-19 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating manic-depressive bipolar disorder |
| WO1998052593A1 (en) * | 1997-05-19 | 1998-11-26 | Repligen Corporation | Method for assisting in differential diagnosis and treatment of autistic syndromes |
-
2000
- 2000-01-18 AU AU26156/00A patent/AU763601B2/en not_active Ceased
- 2000-01-18 MX MXPA01008038A patent/MXPA01008038A/es active IP Right Grant
- 2000-01-18 US US09/484,522 patent/US6552000B2/en not_active Expired - Fee Related
- 2000-01-18 DK DK00904390T patent/DK1152756T3/da active
- 2000-01-18 EP EP00904390A patent/EP1152756B1/de not_active Expired - Lifetime
- 2000-01-18 ES ES00904390T patent/ES2244411T3/es not_active Expired - Lifetime
- 2000-01-18 WO PCT/US2000/001127 patent/WO2000045812A1/en not_active Ceased
- 2000-01-18 CA CA002361584A patent/CA2361584C/en not_active Expired - Fee Related
- 2000-01-18 JP JP2000596932A patent/JP2002536328A/ja not_active Withdrawn
- 2000-01-18 AT AT00904390T patent/ATE299371T1/de not_active IP Right Cessation
- 2000-01-18 PT PT00904390T patent/PT1152756E/pt unknown
- 2000-01-18 TR TR2001/03125T patent/TR200103125T2/xx unknown
- 2000-01-18 DE DE60021252T patent/DE60021252T2/de not_active Expired - Fee Related
- 2000-02-07 AR ARP000100525A patent/AR029334A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE60021252D1 (de) | 2005-08-18 |
| CA2361584A1 (en) | 2000-08-10 |
| US20020035068A1 (en) | 2002-03-21 |
| JP2002536328A (ja) | 2002-10-29 |
| AR029334A1 (es) | 2003-06-25 |
| TR200103125T2 (tr) | 2002-04-22 |
| AU2615600A (en) | 2000-08-25 |
| WO2000045812A1 (en) | 2000-08-10 |
| PT1152756E (pt) | 2005-09-30 |
| ES2244411T3 (es) | 2005-12-16 |
| CA2361584C (en) | 2005-06-14 |
| DK1152756T3 (da) | 2005-10-10 |
| EP1152756A1 (de) | 2001-11-14 |
| DE60021252T2 (de) | 2006-05-18 |
| AU763601B2 (en) | 2003-07-31 |
| US6552000B2 (en) | 2003-04-22 |
| EP1152756B1 (de) | 2005-07-13 |
| MXPA01008038A (es) | 2002-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE308997T1 (de) | Mittel zur behandlung von erkrankungen der speiseröhre | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE447947T1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
| DE60028358D1 (de) | Hmg1 antagonisten zur behandlung von entzündungen | |
| ATE305306T1 (de) | Reboxetin zur behandlung von peripheren neuropathien | |
| ATE275145T1 (de) | Chinazolinderivate zur behandlung von tumoren | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| DE69910368D1 (de) | Pyrazolopyrimidinone cgmp pde5 inhibitoren zur behandlung von sexualfunktionsstörungen | |
| DE60019158D1 (de) | Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| ATE384522T1 (de) | Medikamente zur chemotherapeutischen behandlung von erkrankungen | |
| DE60030554T8 (de) | Verwendungen von et743 zur behandlung von krebs | |
| ATE279386T1 (de) | Retinoide zur behandlung von emphysem | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| DE60035326D1 (de) | Verfahren zur Behandlung von Abwasser | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| DE69737067D1 (de) | Vakzine zur behandlung von mycosen | |
| ATE299371T1 (de) | Antikonvulsiva zur behandlung von autismus | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| DE60006412D1 (de) | Oxazinochinolone zur behandlung von viralen infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1152756 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |